| NAME |
DIDANOSINE 10MG/ML SOLN,ORAL |
| VA GENERIC NAME |
DIDANOSINE |
| DOSAGE FORM |
PWDR,RENST-ORAL |
| FDA MED GUIDE |
Didanosine_Powder_(Videx)_(Dec_2018).pdf |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
10 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| INACTIVATION DATE |
2020-07-15 00:00:00 |
| UNITS |
MG/ML |
| NATIONAL FORMULARY NAME |
DIDANOSINE PWDR,RENST-ORAL |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
DIDANOSINE 10MG/ML ORAL SOLN |
| VA PRODUCT IDENTIFIER |
D0441 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
ML |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4013853 |
| EFFECTIVE DATE/TIME |
-
- 2005-03-10 00:00:00
- STATUS: ACTIVE
-
- 2020-07-15 00:00:00
- STATUS: INACTIVE
|
